The Limited Times

Now you can see non-English news...

Germany buys new corona drug - also helped Donald Trump - Spahn: "like a passive vaccination"


Germany has secured a new antibody-based corona drug. Health Minister Spahn confirmed the purchase.

Germany has secured a new antibody-based corona drug.

Health Minister Spahn confirmed the purchase.

  • The federal government has bought a new Corona * drug for 400 million euros

  • Health Minister Jens Spahn confirmed the purchase.

  • Ex-US President Donald Trump was also treated with the antibody-based agent.

Berlin - The


numbers in





- probably thanks to the



However, there is still great concern.

The new

mutations * of

the virus in


recently ensured that the federal and state governments extended the applicable measures until mid-February - for the time being.

At the same time, the vaccination against corona is only starting slowly.

There is still too little vaccine * available.

Corona funds: Spahn announces purchase of new Covid drug

Exactly at this point in time there is now a message that gives hope:

Germany has secured a new corona drug.

Health Minister

Jens Spahn has



this to

Bild am Sonntag


Accordingly, it is the agent is a novel

drug to antibody




From next week, the monoclonal antibodies will be used in Germany as the first country in the EU.

Initially in university clinics, ”said Spahn about



In total, the federal government has bought 200,000 cans for 400 million euros.

Corona agent based on antibodies acts "like a passive vaccination"

"They work like a passive vaccination,"

said Spahn about the drug.

Accordingly, the antibody drug can especially help in the treatment of high-risk patients.

If they are administered in the early stages of an illness, the agent could help prevent a severe course of Covid, Spahn continued.

A similar corona agent probably also helped Donald Trump

According to media reports, the then US President

Donald Trump * was also

treated with this type of antibody after his corona infection.

Trump received the REGN-COV2 antibody cocktail from the US company Regeneron at the beginning of October.

The active ingredient of REGN-COV2 is a combination of two specially developed


that bind to the so-called spike protein of the coronavirus and can thus deform its structure.

This is to prevent the coronavirus from attacking human cells.

According to Regeneron, the combination of two different antibodies should prevent the Sars-COV2 virus from mutating.

(rjs / afp) * is part of the nationwide Ippen digital editorial network.

Source: merkur

All news articles on 2021-01-24

Similar news:

You may like

News/Politics 2021-01-23T23:55:29.302Z

Trends 24h

News/Politics 2021-06-17T16:55:37.436Z


© Communities 2019 - Privacy